Robert B. Rothermel serves as Executive at CELLEGY PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Robert B. Rothermel has executed 7 insider transactions totaling $34.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 24, 2019 involved purchasing 6,500 shares valued at $10.3K.
Robert B. Rothermel currently holds 133,500 shares of CELLEGY PHARMACEUTICALS INC (CLGY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert B. Rothermel has been a net seller of CLGY stock. They have purchased $55.7K and sold $34.4M worth of shares.
Robert B. Rothermel's most recent insider trade was on May 24, 2019, when they purchased 6,500 shares at $1.58 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 14, 2015 | ADMP | $6.8K | Purchase | 2,000 | $3.40 | Discretionary |
| Aug 13, 2015 | ADMP | $16.5K | Purchase | 5,000 | $3.30 | Discretionary |
| Aug 29, 2014 | ADMP | $22.2K | Purchase | 5,500 | $4.03 | Discretionary |
| Dec 27, 2006 | CLGY | $22.0M | Sale | 20,000 | $1100.00 | Discretionary |
| Dec 20, 2006 | CLGY | $12.4M | Sale | 15,000 | $825.00 | Discretionary |